http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101496910-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C23C14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C23C14-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 |
| filingDate | 2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101496910-B |
| titleOfInvention | A kind of degradable blood vessel support |
| abstract | A kind of degradable blood vessel support, its material is pure iron, and the intravascular stent to being made also carries out plasma surface modification treatment：Oxygen, nitrogen or lanthanum, cerium or strontium element are injected on intravascular stent surface；Or modified material film is deposited on intravascular stent surface, the film thickness of deposition is 10~1000 nanometers, and crystallite dimension is 10~200 nanometers, and the modified material of deposition is lanthanum, cerium, strontium, lanthanum-oxides, cerium oxide, strontium oxide, iron or iron oxide.Or the material of intravascular stent is that principal component is iron, separately contains a kind of iron-based material in the lanthanum, cerium or strontium that atomic percentage conc is 0.01~0.5%.The intravascular stent corrosion resistance is significantly improved, endothelial cell is conducive to be covered on intravascular stent surface, with good biocompatibility, and it has controllable degradation rate, the good supportive of intravascular stent is kept in 36 months after the implantation, while as needed can the fully degraded in vivo later at 6 months. |
| priorityDate | 2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.